(Q34543089)

English

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A prospective evaluation of the biochemical, metabolic, hormonal and structural bone changes associated with bortezomib response in multiple myeloma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

0 references

multiple myeloma

1 reference

based on heuristic

inferred from title

2

object named as

Shmuel Yaccoby

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Maurizio Zangari

1

object named as

Maurizio Zangari

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Lisa Pappas

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Federica Cavallo

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Naveen Sanath Kumar

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Subramanian Ranganathan

6

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Larry J Suva

7

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

J Michael Gruenwald

8

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Steven Kern

9

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Fenghuang Zhan

10

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dixie Esseltine

11

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Guido Tricot

12

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

publication date

15 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

96

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

333-336

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

The proteasome inhibitor, bortezomib suppresses primary myeloma and stimulates bone formation in myelomatous and nonmyelomatous bones in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Randomized trial of once-weekly parathyroid hormone (1-84) on bone mineral density and remodeling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Pharmacologic targeting of a stem/progenitor population in vivo is associated with enhanced bone regeneration in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

The molecular classification of multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Selective inhibitors of the osteoblast proteasome stimulate bone formation in vivo and in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Multiple myeloma disrupts the TRANCE/ osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

7 July 2018

Bortezomib inhibits human osteoclastogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

27 October 2018

Response to bortezomib is associated to osteoblastic activation in patients with multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

27 October 2018

Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-?B ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3031705

9 December 2018

Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Parathyroid responsivity in postmenopausal women with osteoporosis during treatment with parathyroid hormone

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bortezomib increases osteoblast activity in myeloma patients irrespective of response to treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibin A is an endocrine stimulator of bone mass and strength

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The proteasome inhibitor bortezomib affects osteoblast differentiation in vitro and in vivo in multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictive value of alkaline phosphatase for response and time to progression in bortezomib-treated multiple myeloma patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extended follow-up of a phase 3 trial in relapsed multiple myeloma: final time-to-event results of the APEX trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pattern of gene expression following rat tibial marrow ablation

1 reference

https://pubmed.ncbi.nlm.nih.gov/20952514

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2010.031302

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

release_2vlefy4c2zbf7h2ifwpz7pyysm

1 reference

https://api.fatcat.wiki/v0/release/2vlefy4c2zbf7h2ifwpz7pyysm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34543089&oldid=1837637107"